BioLineRx (BLRX) and Dare Biosciences (DARE), NanoCap Biotech Companies with Phase III Trials Completed and Enough Capital to Launch Products
Nanocap biotech companies with enough capital to launch a new product are a sweet spot for investors in the current market.
Source: twst.com